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ABSTRACT
The first critical transition in
follicular development, the activation of primordial
follicles to leave the pool of resting follicles and begin
growth, is poorly understood, but it appears that the
balance between inhibitory and stimulatory factors is
important in regulating the exodus of follicles from the
resting pool. There is evidence that anti-Müllerian
hormone (AMH; also known as MIS) inhibits follicle
activation in mice, but whether it plays a similar role in
non rodent species is not known. When pieces of
bovine ovarian cortex, rich in primordial follicles, are
cultured in serum-free medium, most follicles initiate
growth, but when cortical pieces are grafted beneath
the chorioallantoic membrane (CAM) of chick embryos, follicle activation does not occur. Since embryonic chick gonads of both sexes produce and secrete
high levels of AMH, the hypothesis that the AMH in the
chick circulation inhibits follicle activation was tested.
In Experiment 1, whole newborn mouse ovaries were
grafted beneath the CAM (placed ‘‘in ovo’’) or cultured
in vitro for 8 days. In vitro (or after 8 days in vivo)
follicles activated and proceeded to the primary or
secondary stage, but activation was suppressed in ovo.
This inhibition was reversed if ovaries were removed
from beneath the CAM and cultured in vitro. In
contrast, when ovaries from mice null mutant for the
AMH type II receptor were CAM-grafted in Experiment
2, follicle activation occurred in a similar fashion to
activation in vitro. This finding strongly implicates
AMH as the inhibitor of follicle activation in ovo. Since
chick embryonic gonads are the source of circulating
AMH, chicks were gonadectomized in Experiment 3,
prior to grafting of pieces of bovine ovarian cortex
beneath their CAMs. Bovine primordial follicles activated in the gonadectomized chicks, similar to the
results for mice lacking the AMH type II receptor.
Taken together these experiments provide strong
evidence that AMH is the inhibitor of mouse follicle
activation present in the circulation of embryonic
chicks and provide indirect, and hence more tentative,
evidence for AMH as an inhibitor of bovine follicle
activation. Mol. Reprod. Dev. 71: 480–488, 2005.
ß 2005 Wiley-Liss, Inc.

ß 2005 WILEY-LISS, INC.
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INTRODUCTION
In mammalian ovaries, primary oocytes, the prospective female gametes, are stored within non growing
primordial follicles. In some species primordial follicles
form during fetal life (e.g., primates, cattle, and sheep),
whereas in other species follicle formation does not
occur until after birth (e.g., mice, rats, and pigs). The
mechanisms involved in the activation process,
the transformation from the resting primordial to
the growing primary follicle, and in the timing that
allows some follicles to start growing while others
remain inactive are still largely unknown, especially
for larger mammalian species (reviewed in Fortune,
2003).
Our laboratory has developed two experimental
models that can be used to study primordial follicle
activation in large mammals. The ﬁrst is a serum-free
organ culture system for pieces of ovarian cortex,
the ovarian compartment where primordial follicles
reside. In this in vitro system, primordial follicles in
bovine and baboon ovarian cortex activate and, contrary
to the situation in vivo where only a few follicles activate
at any one time, almost all the primordial follicles
develop to the primary stage within 1–2 days (Wandji
et al., 1996, 1997; Fortune et al., 2000). This suggests
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that gonadotropins or other extra-ovarian factors are
not required for primordial follicle activation and
highlights the potential importance of inhibitory
factors to the regulation of follicle activation in vivo.
The second experimental model consists of grafting
ovarian cortical pieces beneath the chorioallantoic
membrane (CAM) of 6-day-old chick embryos. In this
situation, bovine cortical pieces are rapidly vascularized
and primordial follicles remain healthy, but the wholesale spontaneous activation observed in vitro does
not occur ‘‘in ovo’’ (Cushman et al., 2002), suggesting
that chick embryos produce an inhibitor of follicle
activation.
It is likely that follicle activation in vivo is controlled
by a balance of stimulatory and inhibitory factors.
The results obtained with both the in vitro and in ovo
experimental systems described above highlight the
importance of inhibitory factors and release from their
effects in primordial follicle activation in cattle, a species
of practical interest and an excellent model for human
ovarian function. In mice, anti-Müllerian hormone
(AMH, also known as Müllerian inhibiting substance
or MIS), a member of the transforming growth factor b
superfamily, has been implicated in the inhibition of
follicle activation. Amh null mice are fertile, but their
store of primordial follicles is depleted earlier in life
than in control animals (Durlinger et al., 1999) and
addition of AMH to cultures of mouse ovaries inhibited
follicular activation (Durlinger et al., 2002). We have
hypothesized that the complete inhibition of follicle
activation observed in bovine cortical pieces in ovo is
due to inhibitory effects of AMH in the chick circulation,
since both gonadal and circulating concentrations of
AMH are high for much of chick embryonic life (Hutson
et al., 1981; Teng, 1987).
In the current study, we have explored the nature
of the inhibitory factor that suppresses follicle activation in ovo, using a combination of experiments with
neonatal mouse ovaries and bovine ovarian cortical
tissue in different experimental situations (in ovo,
in vitro, and in vivo). Although large mammals such as
domestic animals and humans are the practical targets
of interest in studying the regulation of follicle growth
initiation, mice are very useful experimental models.
The small size of the ovaries, which allows the culture of
whole ovaries, the fact that follicle formation and the
initiation of follicle growth occur within a short period
after birth, and the availability of mice in which speciﬁc
gene functions have been deleted provide experimental
advantages not available for larger mammals. Speciﬁcally, these experiments were designed to (1) determine
the effects of culture in ovo on whole mouse ovaries,
compared with culture in vitro and with the in vivo
situation, (2) determine, using mice lacking the gene
for the AMH type II receptor (Amhr2), whether AMH is
the (or a) inhibitor of follicle activation in ovo, and (3)
determine whether the gonads, which are the source
of AMH in chick embryos, are the source of the factor
that inhibits activation of bovine primordial follicles
in ovo.
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MATERIALS AND METHODS
Animals and Isolation of Ovarian Tissue
For Experiment 1, female and male C57BL/6J mice
were obtained from the Jackson Laboratory (Bar
Harbor, ME) and bred. Neonatal female pups were
killed by decapitation either within 24 hr of birth (for
control, in vitro, and in ovo groups) or at 8 days of age (in
vivo group). The ovaries were dissected from the pups
and either ﬁxed immediately (control and in vivo
groups), placed in organ culture (in vitro group), or
grafted beneath the CAM of 6-day-old chick embryos
(in ovo group), as described further in the sections below.
For Experiment 2, mice heterozygous for a null mutation in the Amhr2 gene (Jamin et al., 2002) were
obtained from Dr. R. Behringer (M.D. Anderson Cancer
Center, Houston, TX) and bred to obtain homozygous
mutant and wild type progeny. The ovaries were
dissected from female pups within 24 hr of birth and
cultured in vitro or in ovo by methods described below.
For Experiment 3, pieces of bovine ovarian cortex were
obtained during the last third of gestation, as described
previously (Wandji et al., 1996) and then cultured
in vitro or in ovo. All use of live animals was in
accordance with procedures approved by the Cornell
University Animal Care and Use Committee.
Experimental Designs
Experiment 1. Experiment 1 was designed to test
two hypotheses: (1) that follicle activation would be
inhibited in whole mouse ovaries grafted beneath the
chick CAM, similar to previous results for isolated pieces
of bovine ovarian cortex, and (2) that more follicles
would leave the resting pool in mouse ovaries cultured
in vitro compared to litter mates in vivo. To test these
hypotheses, ovaries from newborn mice were either
ﬁxed immediately (control) or grafted beneath the CAM
of chick embryos (in ovo) or placed in organ culture
(in vitro) in Experiment 1A. After 8 days in vitro, in ovo,
or in vivo (i.e., pups left with their mothers for 8 days)
ovaries were retrieved and ﬁxed for histological morphometry as described below.
Based on the results of Experiment 1A, Experiment
1B was conducted to determine if primordial follicles in
CAM grafts retain the ability to activate if the grafts are
removed and cultured in vitro. Therefore, ovaries placed
beneath the CAM were retrieved 2 days after grafting
and then either placed in vitro for 8 days (crossover) or
ﬁxed immediately for histology (day 2 control).
Experiment 2. This experiment was designed to test
the hypothesis that the inhibition of follicle activation
observed in Experiment 1 was due to the high circulating levels of AMH in chick embryos. Ovaries were
isolated 12–36 hr after birth from wild type female pups
and litter mates null mutant for the Amhr2 gene. One
ovary of each pair was grafted beneath the CAM of a
chick embryo and the other was placed in organ culture.
After 4 days in ovo or in vitro, ovaries were retrieved and
ﬁxed for histological studies. Tail tissue of the pups was
used for genotyping, as described below.
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Experiment 3. Since the results of Experiments 1
and 2 suggested that the inhibitor of follicle activation in
the circulatory system of embryonic chicks is AMH, we
hypothesized that AMH is also the inhibitor of follicle
activation in CAM-grafted pieces of bovine ovarian
cortex. Because mutants deﬁcient in AMH or its type
II receptor are not available for cattle, we took an
indirect approach to testing this hypothesis. Since AMH
is produced by embryonic chick ovaries and testes,
destruction of the chick gonads prior to CAM grafting of
bovine cortical pieces should allow follicle activation to
occur in bovine ovarian cortex in ovo, if the hypothesis is
correct. In this experiment bovine cortical pieces,
isolated as described previously (Wandji et al., 1996)
were treated in one of ﬁve ways: (1) ﬁxed immediately
(day 0 control), (2) placed in culture (in vitro control), (3)
grafted beneath the CAM of intact chick embryos (in ovo
control), (4) grafted beneath the CAM of chick embryos
whose gonads had been destroyed by electrocautery, or
(5) grafted beneath the CAM of sham-cauterized chick
embryos (control for cautery). Cortical pieces in groups
2–5 were collected after 2 days and ﬁxed for histological
analysis.
Culture In Vitro
Ovaries of newborn mice or bovine cortical pieces were
cultured in 24-well Costar plates (Corning, Inc., Corning, NY) on uncoated culture plate inserts (Millicell-CM,
0.4 mm pore size, Millipore Corporation, Bedford, MA)
with 300 ml of Waymouth medium MB 752/1 (Invitrogen,
Carlsbad, CA) supplemented with 50 mg streptomycin
sulfate and 75 mg penicillin/ml (Invitrogen), ITSþ
(6.25 mg insulin, 6.25 mg transferrin, 6.25 ng selenious
acid, 1.25 mg BSA, and 5.35 mg linoleic acid per ml;
BD Biosciences, Bedford, MA) and 25 mg/L pyruvic
acid (Sigma Chemical Co., St. Louis, MO). Tissue was
cultured for the periods of time speciﬁed for each
experiment in a humidiﬁed incubator with 95% air:5%
CO2 at 38–38.58C. Every other day, 200 ml of medium
was withdrawn and replaced with fresh medium.
Culture In Ovo and Gonadectomy
Fertilized chicken eggs were obtained from the
Cornell University Poultry Farm and incubated at
388C and 60% humidity. Prior to the experiments, a
window was made in the shells of 3-day-old fertilized
chick eggs. The shell was gently opened and a piece of
shell removed; the eggs were then sealed with a piece
of Scotch-3M tape and returned to the incubator.
CAM grafting was performed using 6-day-old eggs, as
described previously for bovine ovarian cortical pieces
(Cushman et al., 2002). Brieﬂy, neonatal mouse
ovaries or pieces of bovine ovarian cortex were placed
beneath the developing CAM, between the CAM and
the yolk sac (one ovary or cortical piece per embryo).
The grafts were retrieved after 2, 4, or 8 days in ovo.
Retrieved grafts were either ﬁxed immediately for histological studies or, in Experiment 1B, placed in vitro for
a further 8 days and then retrieved for histological
analysis.

In Experiment 3, some chick embryos were gonadectomized or sham cauterized on day 5 of incubation, prior
to CAM-grafting on day 6. The ground lead of a surgical
electrocautery unit was introduced into the thin albumen of the egg through a pinhole in the shell. The
embryo was elevated through the window of the egg with
a smooth glass rod, with care taken to avoid damage to
extraembryonic membranes and blood vessels. The
embryo was cauterized along both sides of its spine to
ablate the gonadal ridge as well as some of the associated
metanephros, using a weak coagulating current. Very
little bleeding resulted from this procedure. The embryo
was then lowered back into the egg, the window in the
shell was re-sealed with fresh tape, the pinhole was
sealed with parafﬁn, and the egg was returned to the
incubator. Sham-operated controls received cautery
treatment to a hind limb. The success of gonadal
destruction was conﬁrmed at the end of the experiment,
when CAM grafts were retrieved.
Histology and Morphometric Analysis of
Mouse Ovaries and Bovine Cortical Pieces
Ovaries were ﬁxed for 1 hr in 2.5% glutaraldehyde,
2.5% formaldehyde in 0.075M cacodylate buffer, pH 7.3
(Tousimis Research Corporation, Rockville, MD). The
ovaries were embedded in LR White plastic (EMS, Fort
Washington, NJ) and 2 mm sections were cut with a glass
knife. To avoid counting the same follicles twice, every
other set of 10 consecutive sections was mounted on
gelatin-coated slides and stained with toluidine blue.
Only the largest section within each set of 10 was
selected for counting and only follicles in which the
oocyte nucleus was present were counted. Follicles
were classiﬁed and measured using an inverted microscope with Hoffman modulation contrast optics. The
image was projected onto a video monitor and the
diameters of all healthy follicles and their enclosed
oocytes were measured using a computer-driven image
analysis program (NIH Image; NIH, Bethesda, MD).
Follicles were classiﬁed as (1) primordial, when there
was a single layer of ﬂattened granulosa cells around the
oocyte, (2) primary, when a single layer of cuboidal
granulosa cells enclosed the oocyte, or (3) secondary,
when the oocyte was surrounded by two or more
complete layers of granulosa cells. In addition, follicles
were classiﬁed as either healthy or atretic. Follicles with
intact basal lamina, an oocyte with no more than three
cytoplasmic vacuoles, an intact germinal vesicle and a
healthy nucleolus were classiﬁed as healthy. Follicles in
which the oocyte had >3 cytoplasmic vacuoles and the
beginning of chromatin condensation were considered to
be early atretic. Follicles with fragmentation of the
oocyte cytoplasm and nucleolus and heavy condensation
of the oocyte chromatin were classiﬁed as moderately
atretic. Advanced atresia was marked by complete
fragmentation or absence of the oocyte.
Genotyping
Female progeny of parents heterozygous for a null
mutation of the Amhr2 gene were genotyped to identify
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homozygous wild type and mutant pups. Genomic DNA
was isolated by incubating tail tissue of newborn mice at
558C for 3 hr in 500 ml 50 nM Tris-HCl pH 8.0, 100 mM
EDTA pH 8.0, 100 mM NaCl, 1% SDS, 1.2 mg/ml
proteinase K (Ambion; Austin, TX), neutralized with
phenol/chloroform/isoamyl alcohol (25:24:1) for 1 hr and
centrifuged (14,000 rpm) for 5 min. The upper phase was
transferred to a fresh microfuge tube and the DNA was
precipitated with an equal volume of 100% ethanol. The
DNA was pelleted by centrifugation (14,000 rpm) for
5 min. The supernatant was removed and the pellet
washed with cold (208C) 70% ethanol, followed by
centrifugation (14,000 rpm) for 5 min. The supernatant
was discarded and the DNA pellet air-dried and then
dissolved in 100 ml TE (10 mM Tris-HCl, pH 7.5, and
1 mM EDTA, pH 8.0).
PCR was performed on 1 ml of DNA using the following
sets of primers: MISr2-Fw8 (50 -AGGTGGGTCAGACCCAGAGC-30 ) and MISr2-Rv9 (5-0 GCATGACCTCCTTCCTGGATT-30 ) to determine the presence of the
wild-type allele (PCR product of 223 bp); Cre-up (50 TCCAATTTACTGACCGTACACCAA-30 ) and Cre-dn
(50 -CCTGATCCTGGCAATTTCGGCTA-30 ) to determine the mutant band (PCR product of 500 bp). All
chemicals for PCR were from Invitrogen (Life Technologies, Rockville, MD). The PCR reaction mixture was
preheated for 5 min at 958C followed by 35 ampliﬁcation
cycles (denaturation at 958C for 30 sec, annealing at
558C for 30 sec, extension at 728C for 45 sec). The
products were visualized by ethidium bromide staining
after electrophoresis on a 2.5% agarose gel.
Statistical Analysis
Mean numbers of total primordial, primary and
secondary follicles per section, mean numbers of healthy
primordial, primary and secondary follicles per section,
and mean diameters of healthy follicles and oocytes were
calculated for each mouse ovary and for the cortical
pieces from each fetal bovine ovary. If Hartley’s test
indicated heterogeneity of variance among means,
values were transformed to logarithms before further
analysis, but only non transformed data are presented in
the ﬁgures. Differences among treatment groups were
tested by one-way ANOVA, followed by Duncan’s
multiple range test when the ANOVA indicated a
signiﬁcant difference.
RESULTS
Experiment 1: Follicular Populations in
Mouse Ovaries In Vivo, In Vitro, and In Ovo
On the day of birth, mouse ovaries contained only
primordial follicles, as expected (Fig. 1, day 0). After
8 days in vivo, some primordial follicles had activated
and developed to the primary or secondary stage. In
vitro, some primordial follicles also had activated and
progressed to the primary or secondary stage, but the
number of primary follicles and the total number of
growing follicles were higher in ovaries maintained
in vitro, compared to contemporaneous ovaries in vivo
(P < 0.05). Ovaries grafted beneath the chick CAM (in
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Fig. 1. Numbers of primordial, primary and secondary follicles
(mean per section  SEM) in mouse ovaries on the day of birth (day 0),
or after 8 days in vivo, in vitro, or in ovo. Within each follicular stage,
bars with no common superscripts are different (P < 0.05; N ¼ 4 ovaries
per group).

ovo) became well vascularized and the small number of
growing follicles present after 8 days did not differ from
ovaries on day 0 (P > 0.05), indicating that, in contrast to
the in vitro and in vivo groups, activation did not occur
in ovo. In all groups, >90% of follicles were healthy (data
not shown). In contrast to the differences observed in
numbers of follicles (Fig. 1), neither follicle nor oocyte
diameters differed among treatment groups, within
each follicular stage (Fig. 2).
To determine, if the suppression of follicle activation
in mouse ovaries in ovo is a reversible effect, ovaries
were retrieved after 2 days in ovo and were then either
ﬁxed for histological assessment or transferred to the
in vitro culture system for an additional 8 days. Ovaries
switched from in ovo to in vitro culture (crossover) had
more primary and total growing follicles at the end of
culture in vitro compared to numbers after 2 days in ovo
(P < 0.05, Fig. 3), showing that mouse primordial
follicles in CAM grafts retain the ability to activate.
Diameters of follicles and their oocytes did not differ
between the day 2 in ovo and crossover groups, but
diameters of secondary follicles and their oocytes in the
in vitro group were greater than in the in ovo and
crossover groups and the diameters of the primary
follicles and their oocytes in the in vitro group were
greater than the in ovo group (Fig. 4).
Experiment 2: Role of AMH Type II Receptor
in Suppression of Follicle Activation In Ovo
To test the hypothesis that the inhibition of activation
observed in ovo is due to the high level of circulating
AMH in chick embryos, one ovary of newborn Amhr2 (þ/
þ) and (/) mice was placed in ovo and the other ovary
was cultured in vitro. Ovaries were retrieved and ﬁxed
after 4 days in ovo or in vitro. In the in vitro group, most
follicles were at the primordial stage, but, as expected, a
number of follicles had activated (Fig. 5B). There was no
effect of genotype on numbers of primordial or growing
(primary plus a few secondary) follicles in vitro. All
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Fig. 2. Mean diameters (mm  SEM) of healthy primordial, primary
and secondary follicles and their oocytes in mouse ovaries on the day of
birth (day 0), or after 8 days in vivo, in vitro, or in ovo. Within each
follicular stage, bars with no common superscripts are different
(P < 0.05; N ¼ 4 ovaries per group).

Fig. 4. Mean diameters (mm  SEM) of healthy primordial, primary
and secondary follicles and their oocytes in mouse ovaries on the day of
birth (day 0) or after 2 days in ovo, 8 days in vitro, or 2 days in ovo
followed by 8 days in vitro (crossover). Within each follicular stage, bars
with no common superscripts are different (P < 0.05; N ¼ 5 ovaries per
group).

ovaries grafted beneath the chick CAM became vascularized and were healthy when they were retrieved after
4 days. Contrary to the situation in vitro, where follicles
of both wild type and Amhr2 null mutant ovaries had
activated, activation occurred in ovo only in ovaries from
Amhr2 (/) mice (Fig. 5A). Amhr2 (/) ovaries had
signiﬁcantly more growing follicles compared to the
Amhr2 (þ/þ) group, showing that the absence of a
functional Amhr2 gene is associated with activation of
primordial follicles when ovaries are grafted beneath
the CAM of chick embryos.

Fig. 3. Numbers of primordial, primary and secondary follicles
(mean per section  SEM) in mouse ovaries on the day of birth (day 0) or
after 2 days in ovo, 8 days in vitro, or 2 days in ovo followed by 8 days
in vitro (crossover group). Within each follicular stage, bars with no
common superscripts are different (P < 0.05; N ¼ 5 ovaries per group).

Experiment 3: Effects of Gonadectomy on Follicle
Activation in Bovine Cortical Pieces In Ovo
The results of Experiment 2 above provide evidence
that AMH in the embryonic chick circulation inhibits
activation of primordial follicles in whole mouse ovaries
grafted in ovo. Experiment 3 was designed to test the
hypothesis that AMH is also the factor that inhibits
activation in pieces of bovine ovarian cortex in ovo. Since
AMH is produced by the developing testes and ovaries of
embryonic chicks, this hypothesis was tested by gona-
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Fig. 6. Effect of gonadectomizing embryonic chicks on follicle
activation in chorioallantoic membrane (CAM)-grafts of bovine ovarian
cortex. Numbers of primordial and primary follicles (mean per
section  SEM) on day 0, after 2 days in vitro, or 2 days after CAMgrafting (in ovo) into intact (control), sham-operated, or gonadectomized (Gdnx) 6-day-old chicks. Within each follicular stage, bars with
no common superscripts are different (P < 0.05; N ¼ 2–3 separate
experiments per group).

gonads, activation had occurred (Fig. 6). The numbers of
healthy primordial and primary follicles followed a
pattern similar to the total numbers of follicles and there
was no effect of treatment on follicle or oocyte diameters
(data not shown).

Fig. 5. Effect of presence (þ/þ) or absence (/) of the gene for the
anti-Müllerian hormone (AMH) type II receptor on the numbers of
primordial and primary follicles (mean per section  SEM), after 4 days
in ovo (A) or 4 days in vitro (B). Within each follicular stage, bars with
no common superscripts are different (P < 0.05; N ¼ 2 ovaries per
group).

dectomizing chicks prior to CAM grafting bovine
ovarian cortical pieces, with intact and sham operated
chicks (cautery of non gonadal area) serving as controls.
As expected, freshly isolated bovine cortical pieces had
mostly primordial follicles and smaller numbers of
primary follicles (Fig. 6, day 0). After 2 days in vitro,
the number of primordial follicles had decreased by
about 75%, whereas primary follicles had increased
concomitantly, indicating that activation occurred in
culture as expected. The numbers of primordial and
primary follicles in cortical pieces CAM-grafted to intact
or sham operated controls were not different from day 0
controls, indicating that activation did not occur in these
situations (i.e., when chick gonads were intact). In
contrast, when cortical pieces were transplanted to
gonadectomized chicks, the number of primordial
follicles after 2 days in ovo was not different from
cultures in vitro (Fig. 6). In addition, in cortical pieces
retrieved from gonadectomized chicks, the number of
primary follicles was about 2.5 times greater than in day
0 controls (P < 0.05) and not different from in vitro
controls (P > 0.05), suggesting that, in the absence of

DISCUSSION
The current results provide the ﬁrst insight into the
potential role of AMH in follicle activation in a large
mammalian species and also provide new evidence to
support the postulated role of AMH in activation of
mouse follicles. Since the ovaries of large mammals
cannot be cultured intact and null mutants are not
available, we used a variety of approaches in ovo with
whole mouse ovaries and bovine cortical pieces. The
results showed that the inhibition of follicle activation
previously documented for bovine ovarian cortical
pieces grafted beneath the CAM of chick embryos
(Cushman et al., 2002) is also evident when whole
newborn mouse ovaries are placed in ovo. In addition,
the inhibition was overcome by CAM-grafting ovaries of
mice lacking functional AMH receptors (Amhr2 null
mutant mice) into intact chicks and by grafting bovine
cortical pieces beneath the CAM of gonadectomized
chicks. The results of these two different experimental
approaches implicate AMH secreted by chick embryonic
gonads as the inhibitor of follicle activation in ovo.
Taken together, these results suggest that AMH is an
inhibitor of follicle activation in large mammals, such as
cattle, as well as in rodents.
Although several lines of evidence suggested that the
activation of primordial follicles is regulated by negative, as well as positive, factors, little was known about
how inhibition is effected in vivo until Durlinger et al.
(1999) analyzed follicular development in Amh null
mutant mice. AMH (also known as MIS) has long been
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recognized as the hormone produced by fetal testes that
regresses the Müllerian ducts during differentiation of
the male reproductive tract (see reviews by Josso et al.,
2001; Teixeira et al., 2001). Although Amh null mutant
mice exhibited the expected deﬁcits in male development, homozygous mutant females initially appeared
normal (Behringer et al., 1994). However, careful
analyses of Amh null mutant mice by Durlinger et al.
(1999) revealed that, although the ovaries of prepubertal and young adult mice have more growing preantral
and small antral follicles than wild type controls, the
stock of primordial follicles becomes depleted earlier in
life. Further support for AMH as an inhibitor of follicle
activation was derived from the ﬁnding that addition of
AMH to cultures of newborn mouse ovaries partially
inhibited the initiation of follicle growth (Durlinger
et al., 2002).
Results of previous experiments in our laboratory
suggest that AMH might also inhibit follicle activation
in cattle. When bovine or baboon ovarian cortical pieces,
rich in primordial follicles, are cultured in vitro, most
primordial follicles activate, but progression to the
secondary stage is rare (Wandji et al., 1996, 1997). We
hypothesized that grafting cortical pieces beneath the
chick CAM, where they could become vascularized,
would promote growth beyond the primary stage.
Contrary to this expectation, the follicle activation that
occurs in vitro was absent in ovo, although the cortical
pieces were rapidly vascularized and follicles remained
healthy for 10 days in ovo (Cushman et al., 2002). Since
chick embryonic gonads of both sexes produce high
levels of AMH (Hutson et al., 1981; Teng, 1987), the
inhibition of follicle activation in ovo suggested that
AMH may negatively regulate follicle activation in large
mammalian species like cattle. However, addition of
recombinant human AMH to cultures of bovine cortical
pieces did not block the wholesale spontaneous activation that occurs in vitro, although it did attenuate the
growth of activated, primary follicles (Cushman and
Fortune, 2003). This ﬁnding led us to take a more
indirect approach in the current experiments to testing
the hypothesis that AMH is a negative regulator of
follicle activation in cattle, using the CAM-graft model
with whole, wild type mouse ovaries and mouse ovaries
lacking the AMH receptor Amhr2 and with bovine
cortical pieces transplanted into gonadectomized chick
embryos.
When newborn mouse ovaries were grafted beneath
the CAM, the activation of follicles, which was observed
after 8 days in vivo or in vitro, was absent. This result is
consistent with our previous ﬁnding that primordial
follicles in pieces of bovine ovarian cortex grafted
beneath the CAM did not active (Cushman et al.,
2002), in contrast to the wholesale activation that occurs
when cortical pieces are cultured in vitro (Wandji et al.,
1996). Thus, the inhibitory effect exerted in ovo was
observed in both the absence (cattle; Cushman et al.,
2002) and presence (mice; current study) of the
medullary compartment of the ovary, suggesting that
absence of the medullary compartment is not a factor in

the inhibition of activation in CAM-grafted bovine
cortical pieces. In ovo, mouse ovaries became vascularized and >90% of follicles were maintained in a healthy
state, similar to results in vivo and in vitro. That the
CAM graft situation does not exert deleterious effects on
mouse primordial follicles is also evidenced by the fact
that activation occurred when mouse ovaries were
retrieved from the CAM after 2 days in ovo and cultured
in vitro in a crossover experiment. This is similar to
previous results when bovine ovarian pieces were
‘‘crossed over’’ from in ovo to in vitro culture (Cushman
et al., 2002).
Interestingly, more follicles in intact mouse ovaries
activated in vitro than in vivo. Although the wholesale
activation observed when bovine or baboon cortical
pieces are cultured (Wandji et al., 1996, 1997) was not
observed in mouse ovaries in vitro, a fairly large
percentage of follicles was growing after 8 days in vitro
or in vivo, about 50% and 25%, respectively. This
suggests that a larger proportion of resting follicles
activates in the ﬁrst ‘‘wave’’ of follicular development. If
this rate of activation were sustained, the follicle pool
would quickly become depleted. The source of ovarian
AMH appears to be growing follicles; AMH or its mRNA
has been detected in granulosa cells of activated follicles
in rats (Hirobe et al., 1994; Baarends et al., 1995), sheep
(Bezard et al., 1988), and cattle (Takahashi et al., 1986).
Hence, the results of our experiments with newborn
mouse ovaries support the idea that the inhibition of
follicle activation by AMH is not initiated until a pool of
growing follicles is established. The activation of a
greater percentage of follicles in mouse ovaries in vitro
versus in vivo suggests that ovaries in vitro are exposed
to lower concentrations of AMH, perhaps due to its
diffusion into the culture medium.
The results with CAM grafts of bovine cortical pieces
and whole mouse ovaries, and the reversibility of the
inhibitory effect of the in ovo situation, suggest that the
chick circulation contains an inhibitor of activation.
Because circulating levels of AMH are high in both male
and female chick embryos, we hypothesized that AMH is
the inhibitory factor. That hypothesis was tested by
grafting the ovaries of mice homozygous for a null
mutation of the AMH receptor II (Amhr2-Cre; Jamin
et al., 2002). Like other TGFb family members, AMH
signaling requires that type I and type II receptors form
heteromeric complexes. Mutant male mice lacking the
AMH type II receptor are a phenocopy of AMH liganddeﬁcient males, showing that the AMH type II receptor
is essential for AMH action (Mishina et al., 1996).
Likewise, Amhr2 mutant females are fertile, as are the
female null mutants for AMH protein (Mishina et al.,
1996). After 4 days in ovo, activation had occurred in the
grafted ovaries of the Amhr2 mutant mice, similar to
activation in vitro in the other ovary of the Amhr2
mutant mice, whereas no activation occurred in ovo in
ovaries of their wild type litter mates. These ﬁndings
strongly suggest that AMH is the factor in the chick
circulation that inhibits the activation of primordial
follicles in whole mouse ovaries.

FOLLICLE ACTIVATION AND AMH
AMH is produced by developing chick gonads and both
ovaries and testes have high levels of AMH for much of
embryonic life (Hutson et al., 1981; Teng, 1987). Thus, to
determine if AMH is also the factor that inhibits follicle
activation in bovine cortical pieces grafted in ovo, the
effects of gonadectomizing chicks on activation of
follicles in grafted pieces of bovine ovarian cortex were
determined. In contrast to the almost complete absence
of activation observed in intact or sham-cauterized
chicks, activation occurred in bovine cortical pieces
grafted beneath the CAM of gonadectomized chick
embryos, similar to the proportion of follicles that
activated in control cortical pieces cultured in vitro.
Although, it is possible that chick gonads secrete
another factor that inhibits follicle activation in cattle,
but not mice, this seems less likely than that AMH is the
inhibitor in ovo of both mouse and bovine follicle
activation. However, thus far we have been unable to
inhibit activation in vitro in bovine ovarian cortical
pieces cultured with graded doses of human recombinant AMH (or in preliminary experiments with rat
recombinant AMH), although AMH did attenuate the
growth of primary follicles, as discussed below (Cushman and Fortune, 2003). However, the current ﬁnding
that gonadectomizing chick embryos overrides the
inhibitory effect of CAM-grafting on follicle activation,
taken together with the results obtained with ovaries of
Amhr2 null mutant mice, suggests that AMH negatively
regulates follicle activation in cattle. In vitro activation
occurs within the ﬁrst 24–36 hr of culture (Fortune et al.,
2000), so failure to observe inhibition by AMH in vitro
may be due to failure of this large molecule (about
150 kDa) to diffuse into the bovine ovarian tissue, which
is much denser than in rodents, in time to inhibit
activation and/or to low potency of the human (and rat)
recombinant AMH with bovine tissue. The ability of
AMH to attenuate the growth of bovine follicles after
activation occurs in vitro (Cushman and Fortune, 2003)
argues for the former explanation. In ovo, vascularization occurs rapidly and this may provide a faster
delivery of AMH to the ovarian cortical piece. More
studies are needed to resolve the apparent contradiction
between the results in ovo and in vitro.
In addition to its role as an inhibitor of follicle
activation in mice, and perhaps cattle, AMH may also
modulate the growth of activated follicles. AMH attenuated the growth in vitro of medium-sized and large
preantral follicles in ovaries cultured with FSH (Durlinger et al., 2001) and of bovine follicles activated
in vitro (Cushman and Fortune, 2003). Although these
results suggest that AMH, in addition to inhibiting
follicle activation, also acts to slow the growth of growing
follicles, McGee et al. (2001) reported that AMH
enhanced FSH-stimulated growth in vitro of mediumsized rat preantral follicles. These apparent species
differences remain to be resolved.
The activation of primordial follicles is the ﬁrst critical
transition in follicular development. Although the
temporal regulation of this transition in individual
follicles is still a complete mystery, there is now evidence
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that speciﬁc factors can stimulate or inhibit this
transition in rodent ovaries. Skinner’s laboratory, using
an experimental model in which neonatal rat ovaries
(containing newly formed primordial follicles) are
cultured for 4 days with potential regulators of follicle
activation, has provided evidence that kit ligand
(Parrott and Skinner, 2000), basic ﬁbroblast growth
factor (Nilsson et al., 2001), leukemia inhibitory factor
(Nilsson et al., 2002), insulin (Kezele et al., 2002), and
bone morphogenetic protein-4 (Nilsson and Skinner,
2003) can increase the percentage of growing follicles.
Conversely, the wholesale activation that occurs when
cortical pieces from fetal or adult bovine ovaries and
fetal baboon ovaries are cultured, and the higher
proportion of follicles that activated in vitro versus in
vivo in neonatal mouse ovaries in the current study,
highlight the importance of negative regulators of
follicle activation. In vivo, whether a particular follicle
activates or remains in the resting pool at a given time
could be due to the balance of positive and negative
regulators in its immediate environment. To date, the
only negative regulator that has been identiﬁed is AMH,
but whether it plays this role in non rodent species was
unknown. The results presented herein provide suggestive, albeit indirect, evidence that AMH also inhibits the
initiation of follicle growth in cattle. More direct
evidence for this tentative conclusion awaits the development of new experimental approaches and/or the
availability of more potent or speciﬁc (i.e., bovine)
preparations of AMH.
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